Nova Wellness Group Berhad (KLSE:NOVA)

KLSE:NOVA Income Statement

Financials in millions MYR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Revenue	45.99	44.14	40.84	45.53	49.14	40.48
Revenue Growth (YoY)	12.08%	8.09%	-10.32%	-7.33%	21.38%	18.14%
Cost of Revenue	20.26	19.85	17.4	13.48	15.19	10.86
Gross Profit	25.73	24.29	23.43	32.06	33.95	29.62
Selling, General & Admin	13.55	14.28	12.89	13.68	15.13	10.94
Research & Development	0.6	0.6	0.26	0.23	0.25	-
Other Operating Expenses	-0.05	-	-	-	-	0.57
Operating Expenses	14.09	14.88	13.79	14.1	15.33	11.03
Operating Income	11.63	9.41	9.64	17.95	18.62	18.59
Interest & Investment Income	0.14	0.14	0.32	0.37	0.48	0.63
Currency Exchange Gain (Loss)	0.07	0.07	0.06	0.15	0.04	0.04
Other Non Operating Income (Expenses)	0.7	0.64	0.89	0.7	1.14	0.02
EBT Excluding Unusual Items	12.55	10.27	10.9	19.17	20.28	19.29
Gain (Loss) on Sale of Assets	-	-	-	0.59	-	0
Pretax Income	12.55	10.27	10.9	19.76	20.28	19.29
Income Tax Expense	3.08	2.54	3.03	4.77	4.18	4.73
Net Income	9.47	7.73	7.87	14.99	16.11	14.56
Net Income to Common	9.47	7.73	7.87	14.99	16.11	14.56
Net Income Growth	35.47%	-1.72%	-47.52%	-6.91%	10.64%	11.93%
Shares Outstanding (Basic)	319	319	319	318	318	318
Shares Outstanding (Diluted)	319	319	319	319	318	318
Shares Change (YoY)	-	-	-0.04%	0.34%	0.01%	-
EPS (Basic)	0.03	0.02	0.02	0.05	0.05	0.05
EPS (Diluted)	0.03	0.02	0.02	0.05	0.05	0.05
EPS Growth	35.52%	-1.72%	-47.48%	-7.27%	10.67%	11.90%
Free Cash Flow	8.33	2.27	4.76	-1.76	3.15	3.63
Free Cash Flow Per Share	0.03	0.01	0.01	-0.01	0.01	0.01
Dividend Per Share	0.016	0.016	0.013	0.021	0.021	0.018
Dividend Growth	28.00%	28.00%	-40.48%	2.44%	13.89%	25.87%
Gross Margin	55.94%	55.04%	57.38%	70.40%	69.09%	73.17%
Operating Margin	25.30%	21.33%	23.60%	39.43%	37.90%	45.93%
Profit Margin	20.59%	17.52%	19.27%	32.92%	32.78%	35.96%
Free Cash Flow Margin	18.12%	5.13%	11.65%	-3.87%	6.42%	8.96%
EBITDA	13.29	11.05	11.16	19.24	19.79	19.36
EBITDA Margin	28.90%	25.02%	27.32%	42.25%	40.27%	47.82%
D&A For EBITDA	1.66	1.63	1.52	1.28	1.17	0.76
EBIT	11.63	9.41	9.64	17.95	18.62	18.59
EBIT Margin	25.30%	21.33%	23.60%	39.43%	37.90%	45.93%
Effective Tax Rate	24.57%	24.69%	27.83%	24.13%	20.60%	24.54%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.